logo

For the Inventor, By the Inventor

Blanmont, Belgium

Claude L Gillet

USPTO Granted Patents = 14

 

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 133(Granted Patents)


Location History:

  • Brussels, BE (1976 - 1987)
  • Blanmont, BE (1982 - 1997)

Company Filing History:

goldMedal7 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal6 out of 11 
 
Continental Pharma Incorporated
 patents
bronzeMedal1 out of 1 
 
Continental Pharma S.a.
 patent

Years Active: 1976-1997

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 5643947 - .omega.-amino-.alpha.-phenylalkanonitrile derivatives (1997-07-01),
2. 5462965 - Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases (1995-10-31),
3. 5288905 - Glycyl urea derivatives as anti-convulsants (1994-02-22),
4. 5278191 - Diphenylmethylaminoacetamide derivatives as anti-convulsants (1994-01-11),
5. 5141960 - Tricyclic glycinamide derivatives as anti-convulsants (1992-08-25),
6. 4853401 - Spiro-hydantoins as aldose reductase inhibitors (1989-08-01),
7. 4738979 - .alpha..sub.2 -blocking derivatives of imidazole (1988-04-19),
8. 4639468 - Derivatives of glycinamide, their preparation and their use (1987-01-27),
9. 4638070 - Heterocyclic amino-alcohol derivatives (1987-01-20),
10. 4562205 - Derivatives of 2-aminoacetic acid (1985-12-31),
11. 4474977 - Amino-alcohol derivatives (1984-10-02),
12. 4338330 - Benzimidazole derivatives, their use, and compositions containing these (1982-07-06),
13. 4228187 - Alkyl and cycloalkylthiophenylalkylaminoalkanols, their salts and the (1980-10-14),
14. 3954871 - 1-(4-Alkylthiopheny)-2-substituted amino-alcohols and their salts (1976-05-04),

Title: Claude L Gillet: Innovator in Cardiovascular and CNS Treatments

Introduction

Claude L Gillet is a notable inventor based in Blanmont, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating cardiovascular dysfunctions and central nervous system diseases. With a total of 14 patents to his name, Gillet's work has had a meaningful impact on medical science.

Latest Patents

One of Gillet's latest patents involves a class of .omega.-amino-.alpha.-phenylalkanonitrile derivatives. These compounds are described as having potential use in the treatment of cardiovascular dysfunctions, such as hypertension. The most interesting compounds in this patent are characterized by specific chemical formulas, where R1 and R2 are methoxy, R3 is hydrido, R4 is isopropyl, R5 is methyl, and R6 is selected from linear alkyl, phenylpropyl, phenylbutyl, and phenylpentyl. Additionally, he has explored the use of heterocyclic amino-alcohol compounds for the treatment of CNS diseases.

Career Highlights

Throughout his career, Claude L Gillet has worked with several prominent companies, including G.D. Searle & Company and Continental Pharma Incorporated. His innovative research and development efforts have contributed to advancements in pharmaceutical treatments.

Collaborations

Gillet has collaborated with notable individuals in his field, including Joseph L Roba and Georges E Lambelin. These partnerships have likely enhanced the scope and impact of his research.

Conclusion

Claude L Gillet's contributions to the pharmaceutical industry, particularly in cardiovascular and CNS treatments, highlight his role as a significant inventor. His ongoing work continues to influence medical advancements and improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…